US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jun 12, 2026 (3 months ago)

Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets)…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

What was recalled

Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 00597-0300-45

Recalling firm
Boehringer Ingelheim Pharmaceuticals, Inc.
Origin
CT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0657-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all